Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
46.52
+0.12 (0.26%)
Nov 21, 2024, 1:49 PM EST - Market open
Ultragenyx Pharmaceutical Market Cap
Ultragenyx Pharmaceutical has a market cap or net worth of $4.29 billion as of November 21, 2024. Its market cap has increased by 38.33% in one year.
Market Cap
4.29B
Enterprise Value
4.39B
1-Year Change
38.33%
Ranking
Category
Stock Price
$46.52
Market Cap Chart
Since January 31, 2014, Ultragenyx Pharmaceutical's market cap has increased from $1.19B to $4.29B, an increase of 261.06%. That is a compound annual growth rate of 12.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 4.17B | 6.13% |
| Dec 29, 2023 | 3.93B | 20.90% |
| Dec 30, 2022 | 3.25B | -43.33% |
| Dec 31, 2021 | 5.73B | -32.17% |
| Dec 31, 2020 | 8.45B | 242.48% |
| Dec 31, 2019 | 2.47B | 12.20% |
| Dec 31, 2018 | 2.20B | 11.33% |
| Dec 29, 2017 | 1.98B | -31.24% |
| Dec 30, 2016 | 2.87B | -34.05% |
| Dec 31, 2015 | 4.36B | 211.25% |
| Dec 31, 2014 | 1.40B | 17.73% |
| Jan 31, 2014 | 1.19B | - |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Axsome Therapeutics | 4.58B |
| Alkermes | 4.52B |
| Integer Holdings | 4.47B |
| TG Therapeutics | 4.47B |
| BridgeBio Pharma | 4.35B |
| Haemonetics | 4.27B |
| Oscar Health | 4.20B |
| ICU Medical | 4.10B |